The stratification of the 156 HCC patients into two groups according to the median MYLK-AS1 expression and the correlation between the clinicopathological characteristics and MYLK-AS1 expression revealed that the TACE treatment, vascular invasion, tumor differentiation, tumor size, and tumor stage were significantly associated with MYLK-AS1 expression (Table 1). Here, MYLK is linked to neoplasm.